Yao, Q. (2023). Comparing milk oligosaccharides across various mammal species and assessing their impacts on intestinal health [Doctoral thesis, Gembloux Agro-Bio Tech,]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/308756 |
Yao, Q., Li, H., Gao, Y., Zheng, N., Delcenserie, V., & Wang, J. (01 January 2023). The Milk Active Ingredient, 2'-Fucosyllactose, Inhibits Inflammation and Promotes MUC2 Secretion in LS174T Goblet Cells In Vitro. Foods, 12 (1), 186. doi:10.3390/foods12010186 Peer Reviewed verified by ORBi |
Yao, Q., Gao, Y., Wang, J. (Crit. Ed.), Zheng, N. (Crit. Ed.), & Fan, L. (Other coll.). (08 October 2022). 2'-Fucosyllactose Remits Colitis-Induced Liver Oxygen Stress through the Gut-Liver-Metabolites Axis. Nutrients, 14 (19), 4186. doi:10.3390/nu14194186 Peer Reviewed verified by ORBi Dataset: https://doi.org/10.3390/nu14194186 |
Fan, L. L.* , Yao, Q.* , Li, H. Y. (Crit. Ed.), Zheng, N. (Crit. Ed.), Wu, H. M. (Other coll.), Wen, F. (Other coll.), & Wang, J. Q. (Other coll.). (June 2022). Protective effects of recombinant lactoferrin with different iron saturations on enteritis injury in young mice. Journal of Dairy Science, 105 (6), 4791 - 4803. doi:10.3168/jds.2021-21428 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Yao, Q., Fan, L., Zheng, N., Blecker, C., Delcenserie, V., Li, H., & Wang, J. (2022). 2'-Fucosyllactose Ameliorates Inflammatory Bowel Disease by Modulating Gut Microbiota and Promoting MUC2 Expression. Frontiers in Nutrition, 9, 822020. doi:10.3389/fnut.2022.822020 Peer Reviewed verified by ORBi Dataset: 10.3389/fnut.2022.822020 |
Yao, Q.* , Li, H.* , Zheng, N. (Crit. Ed.), Wang, J. (Crit. Ed.), Fan, L. (Other coll.), Zhang, Y. (Other coll.), & Zhao, S. (Other coll.). (08 February 2021). Dietary Regulation of the Crosstalk between Gut Microbiome and Immune Response in Inflammatory Bowel Disease. Foods, 10 (2), 1 - 19. doi:10.3390/foods10020368 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |